BREFSA research has been supported by these sponsors
- Advanced Biohealing
- American College of Endocrinology
- American Sleep Medicine Foundation
- Amgen, Inc.
- Anthera Pharmaceutical, Inc.
- Aptiv Solutions
- Ascend Cleveland Clinic
- Astra-Zeneca, LP
- Banner Health
- Boehringer-Ingelheim
- Boston Scientific Corporation
- Bristol-Myers Squibb Company
- Colorado Prevention Center
- Covalent Group, Inc.
- Covance/Clinical Develop
- EO2 Concepts, Inc.
- Eli Lilly and Company
- Forest Research Institute, Inc.
- GE Healthcare
- Genentech, Inc.
- GlaxoSmithKline
- Hoffman-LaRoche, Inc.
- Ingenix Pharma Service, Inc.
- Integrium, LLC/Derma Science
- Invetic Health Clinical, LLC
- LifeNet Health
- Liventa Bioscience, Inc.
- Mederi Therapeutics, Inc.
- MedPace, Inc.
- Medtronic USA, Inc.
- Merck
- MiMedx Group, Inc.
- Mount Sinai School of Medicine
- Neogenix, LLC
- Nielsen BioSciences, Inc.
- Novartis Pharmaceutical Corp.
- Novella Clinical/Oncogenex
- Novo Nordisk
- On-X Life Technologies, Inc.
- PAREXEL International, LLC
- Partners Healthcare
- PRA Health Sciences
- Pulmonx
- Regenesis Biomedical
- Respironics, Inc.
- Rho, Inc.
- Roche Diagnostics Corp.
- Sanofi Aventis, Inc.
- Sanuwave Services, LLC
- Schering-Plough
- Smith & Nephew, Inc.
- Spiracure, Inc.
- St. Jude Medical
- Sucampo
- Tactile Systems
- Takeda
- Thoeorem Clinical Research
- Toronto Rehabilitation Institute
- U.S. Biotest, Inc.
- University Health Network
- University of Missouri
